Nelson Capital Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,000
Closed -$9K 254
2019
Q3
$9K Hold
1,000
﹤0.01% 251
2019
Q2
$11K Hold
1,000
﹤0.01% 226
2019
Q1
$10K Hold
1,000
﹤0.01% 208
2018
Q4
$11K Sell
1,000
-2,000
-67% -$24.8K ﹤0.01% 211
2018
Q3
$51K Hold
3,000
0.01% 128
2018
Q2
$43K Hold
3,000
0.01% 131
2018
Q1
$57K Hold
3,000
0.01% 127
2017
Q4
$49K Hold
3,000
0.02% 136
2017
Q3
$45K Hold
3,000
0.01% 133
2017
Q2
$26K Hold
3,000
0.01% 172
2017
Q1
$16K Sell
3,000
-400
-12% -$1.6K 0.01% 203
2016
Q4
$10K Hold
3,400
﹤0.01% 205
2016
Q3
$16K Hold
3,400
0.01% 194
2016
Q2
$20K Sell
3,400
-300
-8% -$1.91K 0.01% 180
2016
Q1
$22K Hold
3,700
0.01% 160
2015
Q4
$34K Hold
3,700
0.01% 129
2015
Q3
$21K Hold
3,700
0.01% 166
2015
Q2
$41K Hold
3,700
0.01% 126
2015
Q1
$58K Buy
3,700
+1,000
+37% +$15.5K 0.02% 109
2014
Q4
$41K Sell
2,700
-300
-10% -$3.64K 0.02% 131
2014
Q3
$32K Hold
3,000
0.01% 146
2014
Q2
$46K Hold
3,000
0.02% 120
2014
Q1
$54K Hold
3,000
0.02% 111
2013
Q4
$42K Hold
3,000
0.02% 118
2013
Q3
$31K Hold
3,000
0.01% 125
2013
Q2
$23K Buy
+3,000
New +$26.2K 0.01% 135

Other funds holding SGMO

Nelson Capital Management's SGMO Position: Q4 2019 in Review

Nelson Capital Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2019, closing a stake of 1,000 shares — an estimated $9K sold.

Nelson Capital Management first reported a position in SGMO in Q2 2013 and held it in 26 quarters. The position peaked at $58K in Q1 2015. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2019.

  • Nelson Capital Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2019 after selling out during the quarter.
  • Nelson Capital Management sold 1,000 SANGAMO THERAPEUTICS INC shares in Q4 2019, an estimated $9K.
  • Nelson Capital Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 26 quarters.
  • Nelson Capital Management's SANGAMO THERAPEUTICS INC position peaked at $58K in Q1 2015.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2019.

Based on Nelson Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.